Lawrence plc
ECO appoints Aivlosin(Copyright) distributor in Europe
ECO Animal Health Ltd ("ECO"), Lawrence plc's subsidiary which specialises in
the development and distribution worldwide of veterinary pharmaceutical
products, is pleased to announce the appointment of Schering-Plough Animal
Health Corporation ("Schering-Plough") as its exclusive distributor of Aivlosin(Copyright)
for pigs in 19 countries in Europe. This follows the announcement in May 2004
that Aivlosin(Copyright) has been approved by the EMEA (European Agency for the Evaluation
of Medicinal Products), following many years of trials, for the treatment and
prevention of Enzootic Pneumonia in pigs; further approvals for both pigs and
poultry are expected in due course.
Schering-Plough is a leader in the development, sales and distribution of
veterinary pharmaceutical products, vaccines and nutritional products worldwide,
and in America, it has been successfully selling ECO's registered Ivermectin
cattle pour-on product under the CooperMEC(Copyright) brand since 2002.
Peter Lawrence, Chairman of Lawrence, commented:
"ECO enjoys an excellent working relationship with Schering-Plough. I am
confident that together we can obtain a significant share of the European market
for pig medications."
Contacts:
Peter Lawrence
Chairman, Lawrence plc
020 8336 2900
Anthony Spiro
Spiro Financial
020 8949 0428
Emma Kane
RedLeaf Communications Ltd
020 7955 1410
Philip Davies
Charles Stanley & Co. Limited
020 7953 2000
Lawrence plc is a leader in the development, manufacture and distribution of
principally specialist chemical and pharmaceutical products for the animal
health and farming markets worldwide. Our products for these growth markets
Incorporate natural ingredients to promote well being and sustainability. We
achieve our financial goals through the careful and responsible application of
science to generate value for our shareholders.
Our corporate web site www.lawrenceplc.com includes our press releases
together with general information about the company and its subsidiaries. Each
subsidiary also has a web site, which gives further information about that
business and its products.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.